Ageing constitutes a critical impediment to somatic cell reprogramming. We have explored the regulatory mechanisms that constitute age-associated barriers, through derivation of induced pluripotent stem cells (iPSCs) from individuals with premature or physiological ageing. We demonstrate that NF-κB activation blocks the generation of iPSCs in ageing. We also show that NF-κB repression occurs during cell reprogramming towards a pluripotent state. Conversely, ageing-associated NF-κB hyperactivation impairs the generation of iPSCs by eliciting the reprogramming repressor DOT1L, which reinforces senescence signals and downregulates pluripotency genes. Genetic and pharmacological NF-κB inhibitory strategies significantly increase the reprogramming efficiency of fibroblasts from Néstor–Guillermo progeria syndrome and Hutchinson–Gilford progeria syndrome patients, as well as from normal aged donors. Finally, we demonstrate that DOT1L inhibition in vivo extends lifespan and ameliorates the accelerated ageing phenotype of progeroid mice, supporting the interest of studying age-associated molecular impairments to identify targets of rejuvenation strategies.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Mahmoudi, S. & Brunet, A. Aging and reprogramming: a two-way street. Curr. Opin. Cell Biol. 24, 744–756 (2012).
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295–305 (2012).
Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136–1139 (2009).
Wang, B. et al. Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages. PLoS Curr. 3, RRN1274 (2011).
Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010).
Marion, R. M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149–1153 (2009).
Banito, A. et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134–2139 (2009).
Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141–154 (2009).
Suhr, S. T. et al. Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 5, e14095 (2010).
Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140–1144 (2009).
Lapasset, L. et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248–2253 (2011).
Rando, T. A. & Chang, H. Y. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148, 46–57 (2012).
Freije, J. M. & Lopez-Otin, C. Reprogramming aging and progeria. Curr. Opin. Cell Biol. 24, 757–764 (2012).
Schreiber, K. H. & Kennedy, B. K. When lamins go bad: nuclear structure and disease. Cell 152, 1365–1375 (2013).
Osorio, F. G. et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Sci. Transl. Med. 3, 106ra107 (2011).
Gordon, L. B., Rothman, F. G., Lopez-Otin, C. & Misteli, T. Progeria: a paradigm for translational medicine. Cell 156, 400–407 (2014).
Miller, J. D. et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691–705 (2013).
Zhang, J. et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31–45 (2011).
Liu, G. H. et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221–225 (2011).
Nissan, X. et al. Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep. 2, 1–9 (2012).
Scaffidi, P. & Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059–1063 (2006).
Puente, X. S. et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am. J. Hum. Genet. 88, 650–656 (2011).
Cabanillas, R. et al. Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am. J. Med. Genet. A 155A, 2617–2625 (2011).
Margalit, A., Brachner, A., Gotzmann, J., Foisner, R. & Gruenbaum, Y. Barrier-to-autointegration factor—a BAFfling little protein. Trends Cell Biol. 17, 202–208 (2007).
Buganim, Y., Faddah, D. A. & Jaenisch, R. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 14, 427–439 (2013).
Liang, G. & Zhang, Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13, 149–159 (2013).
Soldner, F. & Jaenisch, R. Medicine. iPSC disease modeling. Science 338, 1155–1156 (2012).
Smahi, A. et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405, 466–472 (2000).
Luningschror, P., Stocker, B., Kaltschmidt, B. & Kaltschmidt, C. miR-290 cluster modulates pluripotency by repressing canonical NF-κB signaling. Stem Cells 30, 655–664 (2012).
Takase, O. et al. The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells. PLoS ONE 8, e56399 (2013).
Torres, J. & Watt, F. M. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NF-κB and cooperating with Stat3. Nat. Cell Biol. 10, 194–201 (2008).
Kuo, H. P. et al. Epigenetic roles of MLL oncoproteins are dependent on NF-κB. Cancer Cell 24, 423–437 (2013).
Wang, H. et al. NF-κB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol. Cell. Biol. 27, 4374–4387 (2007).
Onder, T. T. et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598–602 (2012).
Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99–118 (2010).
Pendas, A. M. et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat. Genet. 31, 94–99 (2002).
Varela, I. et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 14, 767–772 (2008).
Osorio, F. G. et al. Nuclear lamina defects cause ATM-dependent NF-κB activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 26, 2311–2324 (2012).
Cau, P. et al. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective. Semin. Cell Dev. Biol. 29, 125–147 (2014).
Adler, A. S. et al. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 21, 3244–3257 (2007).
Tilstra, J. S. et al. NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122, 2601–2612 (2012).
Jurk, D. et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2, 4172 (2014).
Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011).
Kawahara, T. L. et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-dependent gene expression and organismal life span. Cell 136, 62–74 (2009).
Osorio, F. G. et al. Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease. Aging Cell 9, 947–957 (2010).
Han, S. & Brunet, A. Histone methylation makes its mark on longevity. Trends Cell Biol. 22, 42–49 (2012).
De Vos, D. et al. Progressive methylation of ageing histones by Dot1 functions as a timer. EMBO Rep. 12, 956–962 (2011).
Chien, Y. et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125–2136 (2011).
Baker, D. J., Weaver, R. L. & van Deursen, J. M. p21 both attenuates and drives senescence and aging in BubR1 progeroid mice. Cell Rep. 3, 1164–1174 (2013).
Krishnan, V. et al. Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proc. Natl Acad. Sci. USA 108, 12325–12330 (2011).
Daigle, S. R. et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 122, 1017–1025 (2013).
Varela, I. et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437, 564–568 (2005).
Soria-Valles, C. et al. Somatic cell reprogramming using NF-κB inhibitory strategies. Nat. Protoc. Exch. (2015) http://dx.doi.org/10.1038/protex.2015.057
Sanchez, L. et al. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells 29, 251–262 (2011).
Liu, B. et al. Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab. 16, 738–750 (2012).
Xu, C. et al. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22, 972–980 (2004).
Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350–1353 (2009).
We thank R. M. Schmid, H. Algül, T. Schöler, A. R. Folgueras, X. S. Puente, A. A. Ferrando, M. Serrano, H. Li, A. López-Soto, C. Bárcena, M. Gupta and D. Robinton for helpful comments and advice. We also thank F. Rodríguez and M. Roldán for excellent technical assistance, and the Servicio de Histopatología (IUOPA) for histological studies. This work was supported by grants from Ministerio de Economía y Competitividad-Spain (to C.L.-O., P.M. and C.B.), Gobierno del Principado de Asturias and Instituto de Salud Carlos III (RTICC), Spain. The Instituto Universitario de Oncología is supported by Fundación Bancaria Caja de Ahorros de Asturias. C.B. is a recipient of a ‘Miguel Servet’ fellowship from the ISCIII-FIS. P.M. is a member of the Spanish Cell Therapy Network (Tercel). C.L.-O. is an Investigator of the Botin Foundation supported by Banco Santander through its Santander Universities Global Division. This paper is dedicated to the memory of Néstor M.O.
The authors declare no competing financial interests.
Integrated supplementary information
(a) qRT–PCR of OCT4, SOX2, KLF4 and c-MYC in control and NGPS fibroblasts at day 3 of reprogramming. n = 3 independent experiments. (b) Control fibroblasts were transduced with a BANF1-specific shRNA. qRT–PCR of BANF1 mRNA was performed in pLKO.1 and shBANF1 transduced fibroblasts. mRNA mean relative values are represented. n = 3 independent experiments, P = 0.002. (c) BANF1 down-regulation impedes cell reprogramming. pLKO.1 and shBANF1 transduced-fibroblasts were reprogrammed. Plot represents the number of Tra-1-60 positive colonies. n = 3 independent experiments, P = 0.001. (d) Scheme depicting the strategy followed for genome editing of NGPS-iPSCs using CRISPR-Cas9 system. The purpose of this experiment was introducing through homologous-directed repair the BANF1 wild-type sequence in NGPS-iPSCs. (e) Two representative clones from NGPS-iPSCs were analysed by PCR to detect the presence of the recombinant allele. Note that recombinant allele c.34G expression in NGPS-iPSCs notably increased the levels of BAF. Western blot analysis of BAF in edited NGPS fibroblasts (left). Western-blot analysis of BAF in control and NGPS fibroblasts transduced with a retroviral vector containing wild-type BANF1 transgene (right). A representative image is shown of 3 independent experiments. (f) Representative analysis of nuclear envelope abnormalities in fibroblasts derived from NGPS-corrected iPSCs. n = 100 cells assessed in 3 independent preparations, P = 0.001 both comparisons. (g) NGPS fibroblasts transduced with wild-type BANF1 were reprogrammed into iPSCs. The plot represents the number of Tra-1-60 positive colonies. n = 3 independent experiments, P = 0.001. Error bars indicate SEM (∗∗P < 0.01, two-tailed Student’s t test). Unprocessed original scans of blots are shown in Supplementary Fig. 9.
(a) BANF1c.34G>A mutation verified by DNA sequencing of NGPS-iPSCs. (b) RT–PCR analysis of pluripotency markers in representative clones from control and NGPS-iPSCs. RNA from human fibroblasts (HF) and hESC was used as a negative and positive control, respectively. (c) Representative series of hematoxylin-eosin (H&E) stained sections from teratomas produced from control, N-I and N-II-iPSCs are shown. All of them formed teratomas with tissues representing all three embryonic germ layers. Bar, 100 μm. (d) DNA methylation profiling of control and NGPS fibroblasts and iPSCs. NGPS-iPSCs showed methylation patterns indistinguishable from control iPSCs, erasing all the alterations shown by progeroid fibroblasts. Unprocessed original scans of PCRs are shown in Supplementary Fig. 9.
Genes that showed significant differences in methylation status in NGPS fibroblasts as compared with controls were analysed through gene ontology for functional annotation.
(a) NGPS-fibroblasts were transduced either with pBABE-empty vector, IκBα-SR or IKK-kinase inactive (KI) and reprogrammed into iPSCs. Plot represents the number of Tra-1-60 positive colonies. Triplicates were done for each condition and mean values are represented. pBABE versus SR, P = 0.0001; pBABE versus IKK2-KI, P = 0.0002. (b) Control fibroblasts expressing a BANF1-specific shRNA were transduced either with pBABE, IκBα-SR or IKK2-KI and reprogrammed. Plot represents the number of Tra-1-60 positive colonies. n = 3, pBABE versus SR, P = 0.0001; pBABE versus IKK2-KI, P = 0.0001. (c) iPSCs derived from NF-κBi-treated cultures express pluripotency-associated markers in a similar extent to untreated iPSCs. RT–PCR results from representative clones are shown. RNA from human fibroblasts was used as negative control. (d) qRT–PCR of OCT-4 and NANOG in iPSCs derived in the presence of NF-κB inhibitors. n = 3 independent experiments. (e) Relative proliferative values of control-, IKK2-CA or Tax-transduced fibroblasts. (f) qRT–PCR of DOT1L (BANF1, P = 0.008; NGPS-edited, P = 0.006), YY1 (BANF1, P = 0.009; NGPS-edited, P = 0.007), NANOG (BANF1, P = 0.002; NGPS-edited, P = 0.003) and LIN28A (BANF1, P = 0.04; NGPS-edited, P = 0.03) in NGPS corrected fibroblasts. n = 3 independent experiments. (g) qRT–PCR of DOT1L in control and IKK2-CA (P = 0.005) or Tax-transduced fibroblasts is shown (P = 0.003). n = 3 independent experiments. For the experiments with iPSCs, at least three different clones were analysed for each genotype and representative results are shown. Error bars indicate SEM (∗P < 0.05; ∗∗P < 0.01, two-tailed Student’s t test). Unprocessed original scans of PCRs are shown in Supplementary Fig. 9.
(a) Relative proliferation values of control, NGPS and Cas9-edited NGPS fibroblasts. (b) SA-β-gal staining in the same cells. Percentage of cells with positive staining is represented. n = 100 cells assessed in 3 independent fields (also hereafter in similar experiments). P = 0.0002. Bar, 200 μm. (c) Percentage of cells with positive nuclear staining of anti-BrdU antibody. P = 0.0002. (d) Relative proliferation values of control and NGPS fibroblasts transduced with pBABE or BANF1 are represented. CTR versus NGPS, P = 0.001; pBABE versus BANF1, P = 0.002. (e) SA-β-gal staining in the same cells. CTR versus NGPS, P = 0.002; pBABE versus BANF1, P = 0.002. Bar, 200 μm. (f) Percentage of cells with positive nuclear staining of anti-BrdU antibody. Error bars indicate SEM (∗∗P < 0.01, two-tailed Student’s t test).
(a) Western-blot analyses of p53, p21 and p16 proteins in control and NGPS fibroblasts transduced with pBABE or IκBα-superrepressor. β-actin was used as a loading control. A representative image is shown of 3 independent experiments. (b) Senescence induction with hydrogen peroxide (0.1 mM for 2 h) in control fibroblasts transduced with pBABE or IκBα-SR. Percentages of SA-β-gal (P = 0.001) and anti-BrdU positive cells (P = 0.002) are depicted and representative pictures from SA-β-gal staining are shown. n = 100 cells assessed in 3 independent fields (also hereafter in similar experiments). Bar, 200 μm. (c) p16 western-blot analyses in hydrogen peroxide-treated control fibroblasts. β-actin was used as a loading control. (d) NGPS fibroblasts transduced with TP53 shRNA and IκBα-SR were reprogrammed into iPSCs. Plot represents the number of Tra-1-60 positive colonies. n = 3 independent experiments for each condition and mean values are represented. NGPS versus shp53, P = 0.005; shp53 versus SR, P = 0.004. (e) Specific down-regulation of TP53 in NGPS fibroblasts did not affect NF-κB activation. NF-κB electrophoretic mobility shift assay in control fibroblasts transduced with BANF1 shRNA in the presence or absence of TP53 shRNA. Oct-1 probe was used as an endogenous control. Error bars indicate SEM (∗∗P < 0.01, two-tailed Student’s t test). Unprocessed original scans of blots are shown in Supplementary Fig. 9.
(a) Heat map represents unsupervised hierarchical clustering of top-altered secreted protein levels in NGPS and control fibroblasts and MSCs (n = 2). Data are displayed as Log2-transformed expression signals. (b) Heat map represents alterations in proteins annotated as members of the senescence-associated secretory phenotype. Data are displayed as Log2-transformed expression signals.
(a) ATM blockade prevented NF-κB activation in NGPS fibroblasts. NF-κB EMSA in NGPS fibroblasts in the presence or absence of ATM inhibitor. Oct-1 probe was used as an endogenous control. (b) Phospho-ATM western-blot analysis in control fibroblasts transduced either with BANF1 shRNA or the empty vector. Right panel, NF-κB EMSA in control fibroblasts transduced with shBANF1 in the presence or absence of ATMi. (c,d) The expression of wild-type BANF1 prevented ATM and NF-κB activation in NGPS cells. (e) Western-blot analysis of RelA in murine fibroblasts from the indicated genotypes. β-actin was used as a loading control. Mean relative mRNA levels are represented. (f) Enrichment score plot shown was obtained from GSEA analysis of control fibroblasts and iPSC transcriptional profiles (P < 0.05). (g) Mice were treated with two different DOT1L inhibitors (epz-4777 and epz-5676) and, as both inhibitors achieved a similar biological effect, experimental data were pooled. Ki-67 immunohistochemistry of skin from 3-month-old wild-type, untreated and DOT1Li-treated Zmpste24-deficient mice. Bar, 30 μm. (h) Representative photographs of spleen and thymus from 3-month-old wild-type, untreated and DOT1Li-treated Zmpste24-deficient mice. (i,j) Prevention of inflammation-associated alterations in intestinal mucosa. Representative hematoxylin-eosin (H&E) staining micrographs are shown from wild-type, untreated and DOT1Li-treated Zmpste24-deficient mice. Mean mucosa thickness (P = 0.006) and villus (P = 0.005) length were quantified and represented. Bar, 100 μm. n = 4 independent animals for each condition. (k) Colony forming assay in BM-MSCs from untreated and DOT1Li-treated Zmpste24−/− mice. P = 0.005. n = 3-untreated and 4-DOT1Li treated (epz-4777, 2 mice and epz-5676, 2 mice) Zmpste24-deficient mice. Error bars indicate SEM. ∗∗P < 0.01, two-tailed Student’s t test). Representative images are shown in western-blot analyses from 3 independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 9.
About this article
Cite this article
Soria-Valles, C., Osorio, F., Gutiérrez-Fernández, A. et al. NF-κB activation impairs somatic cell reprogramming in ageing. Nat Cell Biol 17, 1004–1013 (2015). https://doi.org/10.1038/ncb3207
This article is cited by
Histopathological and immunohistochemical studies on the influence of orally administration monosodium glutamate, a food additive dependent on time in vivo
The Journal of Basic and Applied Zoology (2022)
Biomarker Research (2021)
Nature Cell Biology (2019)
CSB promoter downregulation via histone H3 hypoacetylation is an early determinant of replicative senescence
Nature Communications (2019)